Which companies discussed GLP-1 Drugs in Health Care in earnings calls?
397 companies mentioned glp-1 drugs across 937 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were West Pharmaceutical Services, Inc. (14 calls), Rhythm Pharmaceuticals, Inc. (12 calls), Cencora, Inc. (11 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.
Mentions over time
Data table
| Quarter | Calls mentioning GLP-1 Drugs |
|---|---|
| 2024Q3 | 95 |
| 2024Q4 | 204 |
| 2025Q1 | 235 |
| 2025Q2 | 144 |
| 2025Q3 | 203 |
| 2025Q4 | 226 |
| 2026Q1 | 274 |
| 2026Q2 | 236 |
| 2026Q3 | 85 |
Companies ranked by mentions
Representative quotes
…injector market to be approximately $2.4 billion, growing at a double-digit CAGR, driven by the adoption of biologics, the emergence of generic GLP-1 therapies, and the broader shift towards self-injection as the preferred modality across multiple chronic care categories. Aidaptus is already supporting customer clinical…
…against highly valuable but technically challenging GPCR targets. Our lead metabolic programs cover several of the most strategically important mechanisms in the sector: GLP-1 agonism, amylin agonism, and the GIP receptor, alongside different sets of endocrine opportunities. The commercial and scientific validation for this mechanism continues…
…range. I'm wondering, if there was anything particular in the quarter to drive that organic growth rate. We know that the generic GLP-1 has just arrived in Canada. Is that having an impact or is there any other particular health trends of note? Hamed Shahbazi (Executives…
…offer a fertility benefit? And then second, we talked about this a little bit in the past, but the conversation around GLP-1s continues to evolve. Some of the big PBMs are talking about employers just offering that type of benefit less. If employers are not offering GLP…
Frequently asked questions
What is GLP-1 Drugs and why are companies discussing it?
Weight-loss and diabetes drugs (Wegovy, Mounjaro, Zepbound) reshaping consumer demand, retail pharmacy economics and bioprocess equipment orders.
Which company mentioned glp-1 drugs most in Health Care in the past year?
West Pharmaceutical Services, Inc. (WST) led with 14 calls referencing glp-1 drugs, most recently on July 23, 2026.
How can I track glp-1 drugs mentions across earnings calls via API?
The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →
Related healthcare themes
Last updated: August 8, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (GLP, glp-1, glp1, glp 1). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.